
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 477
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT07173985 | Strategies for Optimizing a Mailed FIT Program in Appalachia | ||
NCT02113514 | Community Awareness, Resources and Education (CARE I): Project 3 | ||
NCT06868368 | Perceptions of Vaping Products | ||
NCT03175289 | Expiratory Muscle Strength Training in Improving Bulbar Function and Quality of Life in Patients With Head and Neck Cancer | ||
NCT04862650 | Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck | ||
NCT05401097 | IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study) | ||
NCT05845476 | Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation | ||
NCT03525925 | Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors | ||
NCT04662645 | Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers | ||
NCT01798901 | AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia | ||
NCT02536495 | Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer | ||
NCT05972577 | Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study | ||
NCT01521039 | Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease | ||
NCT02465541 | Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors | ||
NCT05873712 | Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome | ||
NCT04269837 | Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer | ||
NCT04205071 | Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer | ||
NCT02797600 | Community Awareness, Resources and Education (CARE II) Project: Project 1 | ||
NCT05379166 | Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome | ||
NCT02992522 | Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma | ||
NCT00201747 | Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer | ||
NCT00624936 | Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes | ||
NCT03307044 | Fractional CO2 Laser Therapy for Survivors of Breast Malignancies | ||
NCT02943642 | Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides | ||
NCT00267696 | Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer | ||
NCT00201669 | A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma | ||
NCT03728361 | Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer | ||
NCT01129180 | Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma | ||
NCT05342571 | A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer | ||
NCT00004173 | Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer | ||
NCT02125019 | Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer | ||
NCT02560883 | Hairy Cell Leukemia Patient Data Registry | ||
NCT05870761 | Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma | ||
NCT06470971 | Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients with Advanced Cancer, CIRES Trial | ||
NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | ||
NCT02677961 | An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry | ||
NCT04754321 | Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer | ||
NCT06089408 | Weighted Blanket Use to Reduce Anxiety in Oncology Patients | ||
NCT01535924 | Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma | ||
NCT00738361 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery | ||
NCT02460237 | HPV Self-Test Intervention in Ohio Appalachia | ||
NCT01764802 | Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer | ||
NCT01850654 | Ohio Colorectal Cancer Prevention Initiative | ||
NCT06630442 | Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment | ||
NCT06448351 | Manipulating E-Cigarette Nicotine to Promote Public Health | ||
NCT01174888 | Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia | ||
NCT05972941 | Nicotine and Tobacco Message Framing Among LGBT Young Adults | ||
NCT04267874 | Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study | ||
NCT02077959 | Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma | ||
NCT05136846 | Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer |